Sumitomo Pharma Co., Ltd.
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
4506 | T
Overview
Corporate Details
- ISIN(s):
- JP3495000006
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区道修町２丁目６番８号
- Website:
- https://www.sumitomo-pharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sumitomo Pharma Co., Ltd. is a research and development-oriented pharmaceutical company focused on creating innovative medicines and healthcare solutions. The company concentrates its R&D and commercial activities in the therapeutic areas of oncology, psychiatry, and neurology. It develops treatments across various modalities, including small molecules, regenerative medicine, and cell therapy. Sumitomo Pharma operates with global business platforms, with a strategic focus on Japan and the United States as its primary markets. The company's mission is to contribute to the betterment of healthcare and fuller lives for people worldwide by translating scientific innovation into real-world solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 08:19 |
Registration Form
確認書
|
Japanese | 8.7 KB | ||
| 2025-11-04 08:13 |
Interim Report
半期報告書－第206期(2025/04/01－2025/09/30)
|
Japanese | 319.2 KB | ||
| 2025-10-31 08:39 |
M&A Activity
訂正臨時報告書
|
Japanese | 41.0 KB | ||
| 2025-06-27 09:05 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 29.6 KB | ||
| 2025-06-26 09:39 |
Registration Form
確認書
|
Japanese | 8.7 KB | ||
| 2025-06-26 09:36 |
Governance Information
内部統制報告書－第205期(2024/04/01－2025/03/31)
|
Japanese | 24.0 KB | ||
| 2025-06-26 09:31 |
Annual Report
有価証券報告書－第205期(2024/04/01－2025/03/31)
|
Japanese | 2.1 MB | ||
| 2025-05-30 09:41 |
M&A Activity
訂正臨時報告書
|
Japanese | 40.7 KB | ||
| 2025-05-14 09:18 |
M&A Activity
訂正臨時報告書
|
Japanese | 36.6 KB | ||
| 2025-04-28 10:06 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 24.3 KB | ||
| 2025-04-28 10:03 |
Regulatory News Service
臨時報告書
|
Japanese | 19.0 KB | ||
| 2025-04-03 09:39 |
M&A Activity
臨時報告書
|
Japanese | 41.7 KB | ||
| 2025-01-31 08:11 |
Regulatory News Service
臨時報告書
|
Japanese | 18.7 KB | ||
| 2024-12-19 07:19 |
Regulatory News Service
臨時報告書
|
Japanese | 19.2 KB | ||
| 2024-11-01 03:30 |
Interim Report
確認書
|
Japanese | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Sumitomo Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sumitomo Pharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sumitomo Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
